Advanced Search

 

Study ID Status Title Patient Level Data
204999 Terminated Comparative Effectiveness of Belimumab Use among SLE Patients in a Commercially Insured US Population: 2010-2014
205024 Completed Skin Acceptability Assessment of 874A in subjects with sensitive skin Under Normal Usage Conditions
205033 Completed A Randomized, Open-Label, Two-Period, Crossover Bioequivalence Study in Healthy Adult Subjects after Single Oral Dosing of a NCH-GSK Acetylcysteine 2% Oral Solution versus a Reference Fluimucil® Acetylcysteine 2% Oral Solution
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205034 Completed An open label study to assess the warming sensation, acceptability and local oral tolerability of NCH-GSK Acetylcysteine 2% Oral Solution, given as a single dose in subjects suffering from productive cough due to upper respiratory tract infection
205035 Completed A randomized, single-center, crossover, comparative bioavailability and adhesion performance study, comparing single administrations of a new scopolamine transdermal delivery system formulation to the currently established reference transdermal delivery system in healthy adult participants.
205045 Completed A clinical study investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice
205051 Completed A Study to Investigate the Antimicrobial Activity of two Test Toothpastes in a Plaque Glycolysis and Regrowth Model
205064 Completed PGx7648: Exploratory PGx analysis of ADRB2 Thr164Ile on risk of severe asthma exacerbation in study 201722
205072 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205084 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205086 Completed Adelphi disease specific program survey: Satisfaction with current treatment in US systemic lupus erythematous patients
205162 Completed PGX7646: Evaluation of relationships between UGT1A1 and UGT1A9 genotypes and cabotegravir pharmacokinetics and tolerability
205173 Not yet recruiting Cross-sectional survey to evaluate quality-of-life impact of GLP-1–related nausea and vomiting in T2DM patients
205181 Completed A Phase I, 14 Day, Randomized, Double-Blind (sponsor unblinded), Placebo-Controlled, Repeat Dose, Ascending Cohort Study to Evaluate the Safety, Tolerability Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic biomarkers of GSK3179106, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205194 Completed Adapt and Perform: the Impact of Increased Dietary Protein on the Metabolic Adaptation to Endurance Running and Subsequent Endurance Performance
205200 Completed A pilot study to assess physical activity and heart rate variability in Indian Children using the LifeInsight BioTelemetry Platform.
205201 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205212 Completed Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
205213 Completed A Phase 2, open-label, controlled, multi-center extension study to evaluate 4-year antibody persistence and booster response following MenABCWY vaccination in healthy adolescents and young adults who previously participated in studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)
205215 Completed A Phase 2b, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of GSK Meningococcal ABCWY Vaccine Administered at Different Schedules Compared to GSK Meningococcal group B vaccine, in Healthy Adolescents
205218 Completed A Phase 3b, Open Label, Controlled, Multi-Center, Extension Study to Assess the Persistence of Bactericidal Activity at 4 to 7.5 Years After Two Dose Primary Series of GlaxoSmithKline Biologicals Meningococcal B Recombinant Vaccine and the Response to a Third Dose in Adolescents and Young Adult Subjects who Previously Participated in Parent Studies V72_41 (NCT01423084) and V72P10 (NCT00661713), Compared to Naïve Healthy Controls
205220 Completed A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women aged 18 to 40 Years

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.